Finally, in breast cancer, 9 out of 213 cases (4.05%) with multiple PIK3CA mutations had PTEN mutations compared with 7 out of 70 cases (10.00%) with a single mutation. This evidence concerns the gene PIK3CA and breast carcinoma.